According to Markntel Advisors Report, Saudi Arabia Diabetes Drug Market is expected to grow at a significant growth rate, and the analysis period is 2025-2030, considering the base year as 2024.Consistent monitoring and evaluating of market dynamics to stay informed and adapt your strategies accordingly. As a market research and consulting firm, we offer market research reports that focus on major parameters including Target Market Identification, Customer Needs and Preferences, Thorough Competitor Analysis, Market Size & Market Analysis, and other major factors. At the end, we do provide meaningful insights and actionable recommendations that inform decision-making and strategy development.

Diabetic drugs aid individuals afflicted with the disease to maintain their blood glucose levels. They cannot heal the patient but they reduce the likelihood of complications.

 

Saudi Arabia Diabetes Drug Market Research Report & Summary:

The Saudi Arabia Diabetes Drug Market size was valued at around USD 2 billion in 2024 and is projected to reach USD 3.4 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 9% during the forecast period (2025-30).                  

Time Period Captured in the Report:

• Historical Years: 2020-2023
• Base Years: 2024
• Forecast Years: 2025-2030

Who are the Key Players Operating in the Saudi Arabia Diabetes Drug Market?

The top companies of the Saudi Arabia Diabetes Drug Market ruling the industry are: 

Novo Nordisk A/S, Takeda, Pfizer, Eli Lilly, Janssen Pharmaceuticals, Astellas, Boehringer Ingelheim, Merck and Co., AstraZeneca, Julphar, Bristol Myers Squibb, Novartis, Sanofi Aventis, and others

Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report– https://www.marknteladvisors.com/query/request-sample/saudi-arabia-diabetes-drug-market.html

(“Kindly use your official email ID for all correspondence to ensure seamless engagement and access to exclusive benefits, along with prioritized support from our sales team.”)

What is included in Saudi Arabia Diabetes Drug Market Segmentation?

The Saudi Arabia Diabetes Drug Market explores the industry by emphasizing the growth parameters and categorizes including geographical segmentation, to offer a comprehensive understanding of the market dynamic.  The further bifurcations are as follows:

• By Insulins
  • Basal- Market Size & Forecast 2020-2030, USD Million
    • Lantus (Insulin Glargine)- Market Size & Forecast 2020-2030, USD Million
    • Levemir (Insulin Detemir)- Market Size & Forecast 2020-2030, USD Million
    • Toujeo(Insulin Glargine)- Market Size & Forecast 2020-2030, USD Million
    • Tresiba(Insulin Degludec)- Market Size & Forecast 2020-2030, USD Million
    • Basaglar (Insulin Glargine) – Market Size & Forecast 2020-2030, USD Million
  • Bolous- Market Size & Forecast 2020-2030, USD Million
    • NovoRapid/Novolog (Insulin Aspart)- Market Size & Forecast 2020-2030, USD Million
    • Humalog (Insulin Lispro)- Market Size & Forecast 2020-2030, USD Million
    • Apidra (Insulin Glulisine)- Market Size & Forecast 2020-2030, USD Million
  • Traditional Insulins- Market Size & Forecast 2020-2030, USD Million
    • Novolin/ Actrapid/Insulatard- Market Size & Forecast 2020-2030, USD Million
    • Humulin- Market Size & Forecast 2020-2030, USD Million
    • Insuman- Market Size & Forecast 2020-2030, USD Million
  • Biosimilar Insulins- Market Size & Forecast 2020-2030, USD Million
    • Insulin Glargine Biosimilars- Market Size & Forecast 2020-2030, USD Million
    • Human Insulin Biosimilars- Market Size & Forecast 2020-2030, USD Million
• By Oral Anti-Diabetic Drugs
  • Biguanides- Market Size & Forecast 2020-2030, USD Million
    • Metformin- Market Size & Forecast 2020-2030, USD Million
  • Alpha-Glucosidase Inhibitors- Market Size & Forecast 2020-2030, USD Million
  • Dopamine D2 receptor agonist- Market Size & Forecast 2020-2030, USD Million
    • Bromocriptin- Market Size & Forecast 2020-2030, USD Million
  • SGLT-2 Inhibitors- Market Size & Forecast 2020-2030, USD Million
    • Invokana (Canagliflozin)- Market Size & Forecast 2020-2030, USD Million
    • Jardiance (Empagliflozin)- Market Size & Forecast 2020-2030, USD Million
    • Farxiga/Forxiga (Dapagliflozin)- Market Size & Forecast 2020-2030, USD Million
    • Suglat (Ipragliflozin)- Market Size & Forecast 2020-2030, USD Million
  • DPP-4 Inhibitors- Market Size & Forecast 2020-2030, USD Million
    • Onglyza (Saxagliptin)- Market Size & Forecast 2020-2030, USD Million
    • Tradjenta (Linagliptin)- Market Size & Forecast 2020-2030, USD Million
    • Vipidia/Nesina(Alogliptin)- Market Size & Forecast 2020-2030, USD Million
    • Galvus (Vildagliptin)- Market Size & Forecast 2020-2030, USD Million
  • Sulfonylureas- Market Size & Forecast 2020-2030, USD Million
  • Meglitinides- Market Size & Forecast 2020-2030, USD Million
• By Non-Insulin Injection Drugs
  • GLP-1 Receptor Agonists- Market Size & Forecast 2020-2030, USD Million
    • Victoza (Liraglutide)- Market Size & Forecast 2020-2030, USD Million
    • Byetta (Exenatide)- Market Size & Forecast 2020-2030, USD Million
    • Bydureon (Exenatide)- Market Size & Forecast 2020-2030, USD Million
    • Trulicity (Dulaglutide)- Market Size & Forecast 2020-2030, USD Million
    • Lyxumia (Lixisenatide)- Market Size & Forecast 2020-2030, USD Million
  • Amylin Analogue- Market Size & Forecast 2020-2030, USD Million
    • Symlin (Pramlintide)- Market Size & Forecast 2020-2030, USD Million
• By Combination Drugs
  • Insulin Combinations- Market Size & Forecast 2020-2030, USD Million
    • NovoMix (Biphasic Insulin Aspart)- Market Size & Forecast 2020-2030, USD Million
    • Ryzodeg (Insulin Degludec and Insulin Aspart)- Market Size & Forecast 2020-2030, USD Million
    • Xultophy (Insulin Degludec and Liraglutide)- Market Size & Forecast 2020-2030, USD Million
  • Oral Combinations- Market Size & Forecast 2020-2030, USD Million
    • Janumet (Sitagliptin and Metformin)- Market Size & Forecast 2020-2030, USD Million
• By Distribution Channel
  • Hospital Pharmacies- Market Size & Forecast 2020-2030, USD Million
  • Retail Pharmacies- Market Size & Forecast 2020-2030, USD Million
  • Online Pharmacies- Market Size & Forecast 2020-2030, USD Million
  • Clinics and Diabetes Centers- Market Size & Forecast 2020-2030, USD Million
• By Region
  • Northern
  • Central
  • Southern
  • Eastern
  • Western

Explore the Complete Saudi Arabia Diabetes Drug Market Analysis Report – https://www.marknteladvisors.com/research-library/saudi-arabia-diabetes-drug-market.html

Saudi Arabia Diabetes Drug Market Driver:

High Prevalence of Diabetes Propelling Market Growth – Due to genetic predispositions and unhealthy lifestyle choices, Saudi Arabia has one of the highest prevalence rates in the world. By 2026, around 24% of the total adult population of Saudi Arabia is expected to have Diabetes which was just around 17.7% in 2021. This rising prevalence is leading the nation to become the 2nd highest in the Middle East and 7th highest globally in diabetes occupancy. An unhealthy lifestyle has resulted in the prevalence of obesity-related problems in Saudi Arabia that majorly pose a threat to several chronic diseases like Type-2 diabetes. An approximate 35.4% of the adult population of Saudi Arabia suffers from obesity. This creates an immense nationwide demand for Diabetes Drugs for the treatment and prevention of diabetes, thereby significantly contributing to the market growth.

Another reason is the country has some of the highest per capita consumption of sugar-filled drinks which worsens the diabetes epidemic. High prevalence rates of the disease result from this sort of sedentary behavior allied with diets full of fat and sugar which fuels the growth of the Saudi Arabia Diabetes Drug Market.

Need personalized insights? Click here to customize this report- https://www.marknteladvisors.com/query/request-customization/saudi-arabia-diabetes-drug-market.html

Why Markntel Advisor Report?

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

For Further Queries:

Contact Us

MarkNtel Advisors

Email at –sales@marknteladvisors.com

Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh – 201301, India